UC87:LSE:LSE-UBS(Lux)Fund Solutions – MSCI Canada UCITS ETF(hedged GBP)A-acc (GBX)

ETF | Others |

Last Closing

USD 2346

Change

+11.25 (+0.48)%

Market Cap

USD 0.05B

Volume

5.10K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.39 (+0.14%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+3.50 (+1.75%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-2.79 (-1.95%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.57%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.10 (+0.58%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.35 (+0.57%)

USD 266.08B
0QZO:LSE 0QZO

+0.10 (+0.09%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.18 (+0.60%)

USD 218.91B
0QZ3:LSE Qualcomm Inc.

-0.86 (-0.53%)

USD 202.26B

ETFs Containing UC87:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.23% 86% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.23% 85% B 80% B-
Trailing 12 Months  
Capital Gain 28.21% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.21% 83% B 78% C+
Trailing 5 Years  
Capital Gain 63.68% 76% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 63.68% 75% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 11.56% 69% C- 71% C-
Dividend Return 11.56% 68% D+ 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.59% 52% F 69% C-
Risk Adjusted Return 85.02% 84% B 90% A-
Market Capitalization 0.05B 42% F 24% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.